EUVIMEDEUVIMED entdecken
Übersichtsarbeit

SSTR-based therapies for gastroenteropancreatic and thoracic neuroendocrine neoplasms

Simona Grozinsky-Glasberg iD, Beata Kos-Kudla

Endocrine Reviews · 15.07.2026 · 47 (4) · 496-511

DOI: 10.1210/endrev/bnag007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 26.03.2026. Verfasst von Simona Grozinsky-Glasberg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neuroendocrine Tumor Unit, ENETS Centre of Excellence, Division of Medicine, Hadassah Medical Organization and Faculty of Medicine, the Hebrew Univer…. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Receptors, Somatostatin, Somatostatin, Pancreatic Neoplasms. Die Arbeit nennt 123 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Somatostatin (SRIF) and its receptors (SSTR) are key players in the regulation of neuroendocrine neoplasms (NEN), with significant implications for diagnosis, prognosis, and treatment. The field of SSTR-targeted drugs/ligands (SRLs) is continuously evolving, with emerging novel therapeutic approaches aiming to address the numerous unmet needs and limitations of the standard-of-care (SOC) SRLs. In the present manuscript, we aim to provide a concise review of the field, focusing on the new and ongoing developments and potential novel approaches to be considered in the future. The paper (1) provides insights into the pathophysiology of SSTR in relation to unmet needs in the SRL efficacy and limitations, (2) presents a state-of-the-art assessment of knowledge on the SOC SRLs, and (3) depicts current ongoing and future research, highlighting areas of insufficient knowledge for SRLs in NEN routine practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsReceptors, SomatostatinSomatostatinPancreatic NeoplasmsThoracic NeoplasmsStomach NeoplasmsAntineoplastic AgentsIntestinal NeoplasmsHumansAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

NENNETSRIFSSTRagonistcarcinoidligandneuroendocrine neoplasmssomatostatinsomatostatin receptors

Substanzen

Receptors, SomatostatinSomatostatinAntineoplastic Agents

Autor:innen und Institutionen

  • Neuroendocrine Tumor Unit, ENETS Centre of Excellence, Division of Medicine, Hadassah Medical Organization and Faculty of Medicine, the Hebrew University, Jerusalem 91120, Israel.
  • Department of Endocrinology and Neuroendocrine Tumors, ENETS Centre of Excellence, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice 40-514, Poland.

ORCID-Profile: Simona Grozinsky-Glasberg

Zitieren

APA

Grozinsky-Glasberg, S., & Kos-Kudla, B. (2026). SSTR-based therapies for gastroenteropancreatic and thoracic neuroendocrine neoplasms. Endocrine Reviews, 47(4), 496-511. https://doi.org/10.1210/endrev/bnag007

Vancouver

Grozinsky-Glasberg S, Kos-Kudla B. SSTR-based therapies for gastroenteropancreatic and thoracic neuroendocrine neoplasms. Endocrine Reviews. 2026;47(4):496-511. doi:10.1210/endrev/bnag007

BibTeX
@article{GrozinskyGlasberg2026,
  author = {Grozinsky-Glasberg, Simona and Kos-Kudla, Beata},
  title = {SSTR-based therapies for gastroenteropancreatic and thoracic neuroendocrine neoplasms},
  journal = {Endocrine Reviews},
  year = {2026},
  volume = {47},
  number = {4},
  pages = {496--511},
  doi = {10.1210/endrev/bnag007}
}
Kostenlos starten →